Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fat; Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05199948
What this trial is testing

Weight, Energy, Lipids, and the Liver (WELL) Study

Who this might be right for
Nonalcoholic Fatty Liver
Ohio State University 74
Post-approval studies (Phase 4)Study completedNCT01006889
What this trial is testing

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 24
Not applicableLooking for participantsNCT05842850
What this trial is testing

Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Who this might be right for
NAFLD
Steno Diabetes Center Copenhagen 8
Not applicableStudy completedNCT02787668
What this trial is testing

A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity

Who this might be right for
Non-alcoholic Fatty Liver DiseaseChildhood ObesityInsulin Resistance
University of Alabama at Birmingham 27
Early research (Phase 1)Study completedNCT01677325
What this trial is testing

The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine

Who this might be right for
NAFLD( Non-alcoholic Fatty Liver Disease )
Fudan University 40
Not applicableUnknownNCT02298439
What this trial is testing

Fatty Liver Patient Registry

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Study completedNCT06104319
What this trial is testing

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 61
Not applicableUnknownNCT04081571
What this trial is testing

Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian

Who this might be right for
NAFLDInsulin ResistanceHepatic Steatosis
Cairo University 1,080
Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Very early researchNot Yet RecruitingNCT07198516
What this trial is testing

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Who this might be right for
NAFLDDiabete Type 2
Fujian Medical University Union Hospital 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271
What this trial is testing

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more
Sotio Biotech Inc. 7
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableStudy completedNCT06697977
What this trial is testing

Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDInsulin ResistanceMetabolic Syndrome+4 more
University of Jordan 27
Not applicableUnknownNCT05738707
What this trial is testing

Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Post-approval studies (Phase 4)Study completedNCT04639414
What this trial is testing

Combined Active Treatment in Type 2 Diabetes With NASH

Who this might be right for
Type 2 DiabetesNon-alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease (NAFLD)
German Diabetes Center 192
Post-approval studies (Phase 4)Study completedNCT02526615
What this trial is testing

Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes

Who this might be right for
Insulin SensitivityType 2 Diabetes
Turku University Hospital 48
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Testing effectiveness (Phase 2)Study completedNCT03256526
What this trial is testing

6-week Safety and PD Study in Adults With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Pfizer 53
Early research (Phase 1)Study completedNCT02974374
What this trial is testing

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Pfizer 16
Not applicableStudy completedNCT03184376
What this trial is testing

Histological Improvement of NASH With Prebiotic

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Calgary 14
Next Page